Furthermore, cytogenetic profiling is crucial in identifying MYC, BCL2, and BCL6 rearrangements in high-grade B-cell lymphomas (HGBL-MYC/BCL2/BCL6), which define cases with aggressive clinical behavior and poor prognosis [8]. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.